Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation

The research was funded by iNOVA4Health UID/Multi/04462, a program financially supported by Fundação para a Ciência e Tecnologia/Ministério da Educação e Ciência (FCT-MCTES), through national funds, and co-funded by FEDER under the PT2020 Partnership Agreement. We also acknowledge funding from FCT-M...

Full description

Bibliographic Details
Main Author: Santos, Inês (author)
Other Authors: Ramos, Cristiano (author), Mendes, Cindy (author), Sequeira, Catarina O. (author), Tomé, Catarina S. (author), Fernandes, Dalila G.H. (author), Mota, Pedro (author), Pires, Rita F. (author), Urso, Donato (author), Hipólito, Ana (author), Antunes, Alexandra M.M. (author), Vicente, João B. (author), Pereira, Sofia A. (author), Bonifácio, Vasco D.B. (author), Nunes, Sofia C. (author), Serpa, Jacinta (author)
Format: article
Language:eng
Published: 2019
Subjects:
cystathionine β-synthase (CBS)
cysteine
cystine/glutamate antiporter system Xc- (xCT)
folate-targeted polyurea dendrimers
glutathione (GSH)
hydrogen sulfide (H2S)
ovarian cancer
platinum drugs
selenium chrysin (SeChry)
Food Science
Nutrition and Dietetics
SDG 3 - Good Health and Well-being
Online Access:http://hdl.handle.net/10362/89812
Country:Portugal
Oai:oai:run.unl.pt:10362/89812

Internet

http://hdl.handle.net/10362/89812

Similar Items